Specimen Transport
Articles & Testing Guides
Education
Outreach Resource Center
- Support Services
- Operations
- Sales and Marketing
- Billing and Finance
- Regulatory
- Examples
- More Resources
- Contact Outreach Team
| Web: | MayoMedicalLaboratories.com |
|---|---|
| Email: | mml@mayo.edu |
| Telephone: | 800.533.1710 |
| International: | 507.266.5700 |
| Values are valid only on day of printing. | |
Diagnosis of C5 deficiency
Investigation of a patient with an absent total
complement (CH[50]) level
Complement proteins are components of the innate immune system.
There are 3 pathways to complement activation:1) the classic
pathway, 2) the alternative (or properdin) pathway, and 3) the lectin
activation (mannan-binding protein, [MBP]) pathway. The classic
pathway of the complement system is composed of a series of
proteins that are activated in response to the presence of immune
complexes. The activation process results in the generation of
peptides that are chemotactic for neutrophils and that bind to immune
complexes and complement receptors. The end result of the
complement activation cascade is the formation of the lytic membrane
attack complex (MAC).
The absence of early components (C1-C4) of the complement cascade
results in the inability of immune complexes to activate the cascade.
Patients with deficiencies of the early complement proteins are unable
to clear immune complexes or to generate lytic activity. These patients
have increased susceptibility to infections with encapsulated
microorganisms. They may also have symptoms that suggest
autoimmune disease and complement deficiency may be an etiologic
factor in the development of autoimmune disease.
More than 30 cases of C5 deficiency have been reported. Most of
these patients have neisserial infections.
7.4-11.7 mg/dL
Low levels of complement may be due to inherited deficiencies,
acquired deficiencies, or due to complement consumption (eg,
as a consequence of infectious or autoimmune processes).
Absent C5 levels in the presence of normal C3 and C4 values
are consistent with a C5 deficiency. Absent C5 levels in the
presence of low C3 and C4 values suggests complement
consumption.
A small number of cases have been described in which the
complement protein is present but is non functional. These rare
cases require a functional assay to detect the deficiency #83392
"C5 Complement, Functional, Serum").
The total complement assay (#8167 "Complement, Total, Serum")
should be used as a screen for suspected complement deficiencies
before ordering individual complement component assays. A
deficiency of an individual component of the complement cascade
will result in an undetectable total complement level.
1. Sonntag J, Brandenburg U, Polzehl D, et al: Complement systems
in healthy term newborns: reference values in umbilical cord
blood. Pediatr Dev Pathol 1998;1:131-135
2. Prellner K, Sjoholm AG, Truedsson L: Concentrations of C1q,
factor B, factor D and properdin in healthy children, and the
age-related presence of circulating C1r-C1s complexes. Acta
Peidiatr Scand 1987;76:939-943
3. Davis ML, Austin C, Messmer BL, et al: IFCC-standardization
pediatric reference intervals for 10 serum proteins using the
Beckman Array 360 system. Clin Biochem 1996;29,5:489-492
4. Gaither TA, Frank MM: Complement. In Clinical Diagnosis and
Management by Laboratory Methods. 17th edition. Edited by JB
Henry. Philidelphia, WB Saunders Company, 1984, pp 879-892.
5. O'Neil KM: Complement defiency. Clin Rev Allergy Immunol
2000;19:83-108
6. Frank MM: Complement deficiencies. Pediatr Clin North Am
2000;47(6):1339-1354